Bio-Rad Laboratories (NYSE:BIO.B) Hits New 1-Year High – Here’s What Happened

Bio-Rad Laboratories, Inc. (NYSE:BIO.B)’s share price reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $365.08 and last traded at $365.08, with a volume of 92 shares trading hands. The stock had previously closed at $309.37.

Bio-Rad Laboratories Stock Performance

The company has a current ratio of 3.14, a quick ratio of 2.33 and a debt-to-equity ratio of 0.11. The firm’s fifty day moving average is $311.90 and its 200 day moving average is $290.30. The company has a market cap of $9.76 billion, a PE ratio of 44.25 and a beta of 0.93.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc is a global provider of innovative products and systems that serve the life science research and clinical diagnostics markets. The company operates through two primary segments: Life Science, which delivers instruments, consumables and software for research applications, and Clinical Diagnostics, which offers quality control materials and reagent systems for blood typing, immunology and molecular testing. Bio-Rad’s product portfolio supports a wide range of applications, including protein analysis, gene expression, cell biology and digital PCR.

In the Life Science segment, Bio-Rad develops and markets technologies such as electrophoresis and imaging systems, chromatography instruments, laboratory consumables and software platforms that streamline experimental workflows.